Levi & Korsinsky announces it has commenced an investigation of Omega Healthcare Investors, Inc. (NYSE: OHI) ("Omega Healthcare" or the "Company") concerning possible violations of federal securities laws. On October 31, 2017, the Company held a conference call to discuss its third quarter results. On the call, Daniel J. Booth, the Company's COO, stated that Omega Healthcare was experiencing "operator performance issues," including issues with Signature Healthcare, one of the Company's top ten operators. On the same call, Robert Stephenson, the Company's CFO, stated that operating revenue for the quarter was approximately $220 million, compared to $225 million for the third quarter of 2016, and that "[t]he decrease was primarily a result of placing Orianna on a cash basis" which caused the Company to record no Orianna revenue for the quarter. To obtain additional information, go to: http://www.zlkdocs.com/OHI-Info-Request-Form-6230 or contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.